ETV5 and endometrial cancer: Pedrola et al. reported that Nuclear Protein 1 (NUPR1) was a direct target of the transcription factor ETV5 in endometrial cancer; the inhibition of NUPR1 reduced cell migration and invasion in vitro and reduced tumor growth and dissemination in an orthotopic endometrial cancer model [6].